Berberine inhibits NLRP3 inflammasome activation by regulating mTOR/mtROS axis to alleviate diabetic cardiomyopathy
- 12 December 2023
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 964, 176253
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (32171127, 82330011)
This publication has 40 references indexed in Scilit:
- Myocardial autophagy activation and suppressed survival signaling is associated with insulin resistance in fructose-fed miceJournal of Molecular and Cellular Cardiology, 2011
- Metabolic Syndrome: Is Nlrp3 Inflammasome a Trigger or a Target of Insulin Resistance?Circulation Research, 2011
- The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistanceNature Medicine, 2011
- AMP-activated Protein Kinase (AMPK) Negatively Regulates Nox4-dependent Activation of p53 and Epithelial Cell Apoptosis in DiabetesJournal of Biological Chemistry, 2010
- Oxidative Stress and Diabetic ComplicationsCirculation Research, 2010
- The InflammasomesCell, 2010
- Diabetic cardiomyopathy, causes and effectsReviews in Endocrine and Metabolic Disorders, 2010
- The NLRP3 Inflammasome: A Sensor for Metabolic Danger?Science, 2010
- Differential Regulation of Caspase-1 Activation, Pyroptosis, and Autophagy via Ipaf and ASC in Shigella-Infected MacrophagesPLOS Pathogens, 2007
- Diabetic Cardiomyopathy RevisitedCirculation, 2007